Alcon爱尔康品牌怎么样 申请店铺

我要投票 Alcon爱尔康在医疗器械行业中的票数:848 更新时间:2025-09-19
Alcon爱尔康是哪个国家的品牌?「Alcon爱尔康」是爱尔康(中国)眼科产品有限公司旗下著名品牌。该品牌发源于美国,在1945年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Alcon爱尔康品牌出海!将品牌入驻外推网,定制Alcon爱尔康品牌推广信息,可以显著提高Alcon爱尔康产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

Alcon爱尔康怎么样

始于1945年美国,2008年被诺华公司收购,全球眼科领域的领先者,专业研究、发展、服务及制造光学及眼科产品的世界级厂商


爱尔康公司 (Alcon Laboratories, Inc.) 成立于1945年,是全球较大的眼科药品与医疗器械专业公司。在全球75个国家和地区设有分公司,拥有15,000多名员工,5个研发中心,14个生产工厂,产品销售遍及180多个国家和地区。

2008诺华公司收购眼部护理公司Alcon股份。合并完成后,爱尔康成为诺华旗下第二大的部门。视康(CIBA VISION)和选出的数种诺华眼科医药将被整合进爱尔康,从而形成销售额超过87亿美元、覆盖超过70%的眼科护理领域的组织。

爱尔康的使命是通过创新型产品,提高视觉质量,提高生活品质。这个使命意味着爱尔康22000多名员工为“保护、恢复和提高视力”的目标进行着不懈的努力与奋斗,使散光治疗,青光眼治疗,近视眼激光视力恢复矫正等等技术得到更好,努力改善更多人的视力健康。

在全球范围内,爱尔康有近2000名员工专注于研发工作,以满足世界上迫切的眼部护理需求。

此外,爱尔康与眼科保健专业人士和人道主义组织建立了紧密的合作关系,共同专注于医疗使命并在世界上需要救助的社区进行防盲活动。世界上存在着很多未解决的眼科问题,全世界有数百万人不能得到常规性眼科护理,大量实质性工作亟待完成。基于数十年的专业经验,爱尔康将继续专注于促进眼科保健行业的发展。

爱尔康于1995年作为法人实体进入中国。今天,爱尔康中国在全国范围内拥有700余名员工服务于我们的眼科保健专家。我们的企业目标是在手术产品、药品及视力保健领域成为患者的选择。爱尔康中国一贯秉承其对中国眼科医生及患者的承诺,不断加强相互间的合作,携手共创辉煌的明天。

爱尔康中国同中华医学会眼科学分会紧密合作,举办各种规模及各种类型的学术研讨会,全国眼科年会,以及国际眼科会议;为国内眼科医生的学术交流活动创造平台,为推动中国眼科事业的发展做出不懈的努力。此外,爱尔康中国还同中国残联,健康快车等慈善机构紧密合作,支持各种扶贫项目,为中国的防盲治盲工作贡献力量。


Founded in 1945 in the United States and acquired by Novartis in 2008, Alcon laboratories, Inc., a global leader in ophthalmology and a world-class manufacturer specializing in research, development, service and manufacturing of optical and ophthalmic products, was established in 1945 as the world's largest professional company of ophthalmic drugs and medical devices. It has branches in 75 countries and regions, more than 15000 employees, 5 R & D centers, 14 production plants, and product sales in more than 180 countries and regions. In 2008, Novartis acquired the shares of Alcon, an eye care company. After the merger, Alcon became the second largest division of Novartis. Cibavision and several selected Novartis ophthalmic medicines will be integrated into Alcon to form an eye care organization with sales of over $8.7 billion and coverage of over 70%. Alcon's mission is to improve visual quality and quality of life through innovative products. This mission means that more than 22000 employees of Erkang are making unremitting efforts and struggles for the goal of "protecting, restoring and improving vision", so that astigmatism treatment, glaucoma treatment, myopia laser vision restoration and correction and other technologies can be better, and efforts can be made to improve the visual health of more people. Globally, Alcon has nearly 2000 employees focused on R & D to meet the world's urgent eye care needs. In addition, Alcon has established a close partnership with eye care professionals and humanitarian organizations to focus on medical missions and carry out anti blindness activities in communities in need of assistance around the world. There are many unsolved ophthalmic problems in the world, millions of people in the world can not get routine ophthalmic care, and a lot of substantive work needs to be completed. Based on decades of professional experience, Alcon will continue to focus on promoting the development of eye care industry. Alcon entered China as a legal entity in 1995. Today, Alcon China has more than 700 employees serving our eye care experts nationwide. Our business goal is to be the choice of patients in the field of surgical products, drugs and vision care. Elkon China has always adhered to its commitment to Chinese ophthalmologists and patients, and constantly strengthened mutual cooperation to create a brilliant tomorrow hand in hand. Erkang China, in close cooperation with the ophthalmology branch of the Chinese Medical Association, has held various scale and types of academic seminars, national annual ophthalmology conference and international ophthalmology conference, created a platform for academic exchange activities of domestic ophthalmologists, and made unremitting efforts to promote the development of ophthalmology in China. In addition, elkham China has also worked closely with China Disabled Persons' Federation, health express and other charities to support various poverty alleviation projects and contribute to China's anti blindness work.

本文链接: https://brand.waitui.com/ed7309435.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

政策体系日趋完善加速脑机接口技术落地

近日,国家药品监督管理局最新批准发布了《采用脑机接口技术的医疗器械术语》医疗器械行业标准。该标准明确界定了采用脑机接口技术的医疗器械相关术语与定义,将于2026年1月1日正式实施。对此,中国人工智能产业发展联盟工作组专家高泽龙表示,这一标准的发布能有效破解行业长期存在的术语混乱、概念模糊等痛点,为脑机接口医疗领域的研发、审评、监管及临床应用搭建起“通用语言”体系,从基础层面为我国“脑机接口+医疗”的高质量发展筑牢根基。(证券日报)

8分钟前

宽松周期进一步确认,大宗商品价格支撑显著

美联储降息“靴子”如期落地,9月18日黄金、白银、铜等期货价格冲高回落,原油期货价格也下挫。短期内降息预期被市场提前交易,同时也意味着全球宽松周期进一步确认。美联储降息后美元指数下跌、美元贬值,以美元计价的黄金、铜等商品价格或获支撑,原油商品价格年内或维持震荡下行趋势。(上证报)

8分钟前

软银将在愿景基金裁员近20%

据媒体援引一份备忘录和一位知情人士报道,软银集团将在全球范围内裁掉其愿景基金团队近20%的员工。愿景基金目前拥有44名员工。剩余员工将为创始人孙正义的人工智能AI计划投入更多资源,例如拟投资5000亿美元的星门项目(Stargate)。愿景基金发言人证实了裁员的消息,但没有对细节发表评论。(新浪财经)

8分钟前

华泰证券:降息落地后金价短期或承压,长期配置价值不变

36氪获悉,华泰证券研报称,短期由于美联储降息利好已被充分定价,黄金可能面临“卖事实”的回调压力。本次降息属于预防式降息,金价可能在降息之后一定时间形成“阶段性”顶部。华泰证券认为中长期黄金配置价值不变,一方面,联储在经济上调、通胀粘性的背景下仍延续降息路径,叠加市场对2026年鲍威尔任期结束后联储可能更宽松的预期,长期美经济滞胀的隐忧仍在。另一方面,在全球格局重塑的年代,去美元化趋势、地缘政治风险以及投资组合多元化的需求,都在推动全球央行和机构投资者持续增配黄金。

8分钟前

利率超2%大额存单额度告急,转让市场交易活跃

当前,银行存款利率普遍降至2%以下。记者发现,华瑞银行、网商银行等民营银行仍可提供利率超2%的大额存单。总体来看,此类高息产品不仅额度紧张、销售迅速,在“二手”市场中也备受青睐。(中证网)

8分钟前

本页详细列出关于Alcon爱尔康的品牌信息,含品牌所属公司介绍,Alcon爱尔康所处行业的品牌地位及优势。
咨询